IGF2BP3 and rheumatoid arthritis: The results also revealed the regulatory mechanism by which CEL affects RA‐FLS and macrophages, and confirmed the regulatory significance of the IGF2BP3/RASGRF1/mTORC1 axis in CEL‐mediated reductions in cell proliferation and inflammatory activation.